Neoadjuvant chemotherapy outcome with taxane-based versus non-taxane protocols in gastric cancer
BACKGROUND: Gastric cancer is the fifth most common cancer worldwide. One of the chemotherapy agents, taxanes is important in increasing patients' survival. The purpose of this study is to assess the efficacy of taxane-based drugs versus non-taxanes in neoadjuvant chemotherapy in non-metastatic...
Saved in:
Main Authors: | Shirin Kianersi (Author), Sina Salari (Author), Hamid Rezvani (Author), Mohammad A Araskhan (Author), Alireza Shirangi (Author), Mohammad R Fathi (Author), Mahmoud D Ghorbi (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Taxanes in adjuvant and neoadjuvant therapy for breast cancer
by: S. V. Limareva
Published: (2014) -
Cell death in cancer chemotherapy using taxanes
by: Ana P. Xu, et al.
Published: (2024) -
Platinum and Taxane Based Adjuvant and Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Narrative Review
by: Hao Tian, et al.
Published: (2021) -
Supplemental Preparations in Taxane-Induced Neuropathy Management
by: AmirHosein Sanei, et al.
Published: (2023) -
A Bayesian Network Meta-Analysis for Identifying the Optimal Taxane-Based Chemotherapy Regimens for Treating Gastric Cancer
by: Dan Zhang, et al.
Published: (2019)